Someshwar Navhat

Title: Someshwar Navhat: Innovator in Pharmaceutical Composition

Introduction

Someshwar Navhat is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that aid in managing glucose levels in subjects.

Latest Patents

Navhat holds a patent for a pharmaceutical composition that includes a dipeptidyl peptidase-IV inhibitor. This patent application relates to an oral pharmaceutical composition that features a specific pyrrolidine derivative as a DPP-IV inhibitor, along with a pharmaceutically acceptable excipient. More specifically, the invention focuses on pharmaceutical compositions that incorporate melogliptin and a pharmaceutically acceptable excipient. It also details processes for preparing the pharmaceutical composition and its application in reducing glucose levels in subjects. Additionally, the invention addresses an impurity associated with melogliptin. He has 1 patent to his name.

Career Highlights

Someshwar Navhat is currently associated with Glenmark Pharmaceuticals S.A., where he continues to innovate in the pharmaceutical sector. His work is pivotal in advancing treatments for diabetes and related conditions.

Collaborations

Some of his coworkers include Ulhas R Dhuppad and Vaijnath Aravat, who contribute to the collaborative efforts in research and development at Glenmark Pharmaceuticals.

Conclusion

Someshwar Navhat's contributions to pharmaceutical innovations, particularly in glucose management, highlight his role as a key inventor in the industry. His work continues to impact the field positively.